Both in Pharmaceuticals
Tilray Brands vs Indaptus Therapeutics
Over the past year TLRY returned −81.1% and INDP returned −4.0%; their daily moves had a correlation of 0.05.
TLRY −81.1% INDP −4.0%Growth of $1, one year, split-adjusted
| Metric | TLRY | INDP |
|---|---|---|
| Price | $2.53 | $3.09 |
| Market cap | $373.9M | $411.7M |
| Today | −4.17% | −7.49% |
| 1 month | −29.1% | +45.8% |
| 6 months | −58.9% | +44.4% |
| Year to date | −72.0% | +6.2% |
| 1 year | −81.4% | −7.5% |
| Revenue growth (YoY) | +22.7% | — |
| Gross margin | 30.1% | — |
| Net margin | −16.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | — |
| Net cash | $16.6M | $11.6M |
| Dividend yield | — | — |
| Volatility (60d) | 47.1% | 191.8% |
| Short % of float | 14.6% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).